Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             30 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer Kanai, Masashi
2010
68 1 p. 157-164
artikel
2 Can localised 19F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response? McIntyre, Dominick J. O.
2010
68 1 p. 29-36
artikel
3 Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis Speeten, Kurt Van der
2010
68 1 p. 147-156
artikel
4 Cryptotanshinone has diverse effects on cell cycle events in melanoma cell lines with different metastatic capacity Chen, Lei
2010
68 1 p. 17-27
artikel
5 Difluorodeoxyuridine plasma concentrations after low-dose gemcitabine during chemoradiation in head and neck cancer patients Specenier, P.
2010
68 1 p. 185-191
artikel
6 Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer Kim, Jung A.
2010
68 1 p. 177-184
artikel
7 Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors Benjamin, Robert S.
2010
68 1 p. 69-77
artikel
8 High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid Heinz, Werner J.
2010
68 1 p. 239-245
artikel
9 Hyaluronic acid–paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts Stefano, Ilaria De
2010
68 1 p. 107-116
artikel
10 Inhibition of N-linked glycosylation by tunicamycin induces E-cadherin-mediated cell–cell adhesion and inhibits cell proliferation in undifferentiated human colon cancer cells Freitas Junior, Julio Cesar Madureira de
2010
68 1 p. 227-238
artikel
11 Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice Wu, Zhen-Qian
2010
68 1 p. 87-96
artikel
12 In vitro and in vivo antitumor effects of (4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone Magalhães, Hemerson Iury F.
2010
68 1 p. 45-52
artikel
13 Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study Fransvea, Emilia
2010
68 1 p. 79-86
artikel
14 Lentivirus-mediated inhibition of Med19 suppresses growth of breast cancer cells in vitro Li, Li-Hua
2010
68 1 p. 207-215
artikel
15 Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer Xenidis, Nikolaos
2010
68 1 p. 63-68
artikel
16 Multimodal therapy for liver cirrhosis patients with advanced hepatocellular carcinoma Nagai, Hidenari
2010
68 1 p. 139-145
artikel
17 Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study Muñoz-Casares, Francisco C.
2011
68 1 p. 267-274
artikel
18 Novel small molecule drugs inhibit tumor cell metabolism and show potent anti-tumorigenic potential Trojel-Hansen, Christina
2010
68 1 p. 127-138
artikel
19 Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial Cascinu, Stefano
2010
68 1 p. 37-43
artikel
20 Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors Brendel, Erich
2010
68 1 p. 53-61
artikel
21 Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy Horimatsu, Takahiro
2011
68 1 p. 263-266
artikel
22 Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement Tsimberidou, Apostolia M.
2010
68 1 p. 247-253
artikel
23 Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer Lim, Taekyu
2011
68 1 p. 255-262
artikel
24 Preclinical toxicity and toxicokinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductase R2 Ferdinandi, Eckhardt S.
2010
68 1 p. 193-205
artikel
25 Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study Shin, Dong-Yeop
2010
68 1 p. 165-175
artikel
26 Review on clinical trials of targeted treatments in malignant mesothelioma Jakobsen, Jan Nyrop
2011
68 1 p. 1-15
artikel
27 Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab Polyzos, Aris
2010
68 1 p. 217-223
artikel
28 Sandostatin desensitization–a strategy useful for patients with carcinoid tumors, intolerant to sandostatin Vinjamaram, Sanjay
2010
68 1 p. 225-226
artikel
29 Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868 Jordheim, Lars Petter
2010
68 1 p. 97-105
artikel
30 Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells Wilmes, Anja
2010
68 1 p. 117-126
artikel
                             30 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland